Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › TN › Millington › NPI 1588116891
Physician

Hamad Ahmad MD PC

Hamad Ahmad MD PC was paid $2.63M by Medicaid between Jan 2018 and Dec 2024, across 84 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 26% of everything it billed.

33Billing provider infoHAMAD AHMAD MD PC
MILLINGTON, TN 38053
33aNPI1588116891assigned 11/03/2016
28Total paid$2.63M
24GClaims116,926
24DCodes billed84
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Family Medicine Physician providers in Tennessee

Rank by total paid#24 of 754
Median peer was paid$34K
This provider vs. median78×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$100K$200K$300K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
20188,326$173K
20198,341$183K
202011,906$383K
202128,505$848K
202220,991$480K
202321,702$323K
2024incomplete17,155$237K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 26% 15,812 11,773 $672K
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 18% 14,367 11,328 $472K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 15% 4,347 2,332 $394K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) 12% 11,298 6,080 $319K
99203 Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity 8.2% 3,973 3,257 $215K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 3.2% 5,876 3,552 $84K
0240U 3.1% 692 540 $80K
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 2.7% 6,226 2,948 $72K
87811 Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) 2.0% 1,520 1,317 $52K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 1.7% 5,496 2,177 $45K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 1.5% 3,893 2,893 $39K
95165 Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials 1.3% 252 105 $34K
72 more codes
99497 1.1% 790 $29K
99395 Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years <1% 263 $16K
96110 Developmental screening, with scoring and documentation, per standardized instrument <1% 363 $10K
93000 <1% 1,011 $10K
96160 <1% 838 $9K
99354 <1% 192 $5K
81025 <1% 964 $5K
J1030 Injection, methylprednisolone acetate, 40 mg <1% 902 $5K
99215 Doctor's office visit, returning patient (complex) <1% 101 $5K
92552 <1% 278 $4K
96127 <1% 1,259 $4K
81003 <1% 2,729 $4K
99204 Doctor's office visit, new patient (more involved) <1% 55 $4K
71046 Radiologic examination, chest; 2 views <1% 333 $4K
99396 Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years <1% 59 $3K
80305 <1% 500 $3K
96136 <1% 135 $3K
82962 <1% 1,359 $3K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 191 $2K
99442 <1% 111 $2K
87631 <1% 14 $2K
99401 <1% 97 $2K
99402 <1% 33 $2K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 63 $1K
96103 <1% 82 $1K
99173 <1% 204 $1K
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) <1% 16 $1K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 1,018 $967.37
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) <1% 15 $912.26
G0396 Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes <1% 60 $849.13
99406 <1% 172 $755.37
96120 <1% 27 $648.12
90674 <1% 46 $568.72
0002A <1% 14 $499.14
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 1,284 $474.27
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 286 $411.06
82947 <1% 191 $363.23
0001A <1% 15 $360.00
36415 Collection of venous blood by venipuncture <1% 199 $336.61
99441 <1% 18 $245.79
H0049 Alcohol and/or drug screening <1% 33 $202.00
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 39 $194.89
87806 <1% 19 $75.67
G0442 Annual alcohol misuse screening, 5 to 15 minutes <1% 18 $46.23
J7644 Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram <1% 124 $19.29
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg <1% 179 $5.67
3008F <1% 16,918 $0.04
3077F <1% 778 $0.02
4145F <1% 554 $0.02
2000F <1% 1,594 $0.02
0513F <1% 422 $0.02
3079F <1% 743 $0.02
3078F 0% 790 $0.00
1158F 0% 147 $0.00
G8427 Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications 0% 378 $0.00
G8417 Bmi is documented above normal parameters and a follow-up plan is documented 0% 256 $0.00
1124F 0% 455 $0.00
G8730 Pain assessment documented as positive using a standardized tool and a follow-up plan is documented 0% 80 $0.00
G8731 Pain assessment using a standardized tool is documented as negative, no follow-up plan required 0% 87 $0.00
G8752 Most recent systolic blood pressure < 140 mmhg 0% 261 $0.00
G9287 Antibiotic regimen not prescribed within 10 days after onset of symptoms 0% 84 $0.00
G8753 Most recent systolic blood pressure >= 140 mmhg 0% 13 $0.00
G8938 Bmi is documented as being outside of normal parameters, follow-up plan is not documented, documentation the patient is not eligible 0% 15 $0.00
G8510 Screening for depression is documented as negative, a follow-up plan is not required 0% 265 $0.00
3080F 0% 191 $0.00
3074F 0% 806 $0.00
4050F 0% 1,111 $0.00
3075F 0% 153 $0.00
G8754 Most recent diastolic blood pressure < 90 mmhg 0% 276 $0.00
3048F 0% 17 $0.00
G9459 Currently a tobacco non-user 0% 32 $0.00
G9313 Amoxicillin, with or without clavulanate, not prescribed as first line antibiotic at the time of diagnosis for documented reason 0% 49 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialAHMAD, HAMAD (MEDICAL DIRECTOR)
Same official

Other billing entities under AHMAD, HAMAD

Full network →
ProviderLocationPaid
Hamad Ahmad MD PCBartlett, TN$917K
Hamad Ahmad MD PCGermantown, TN$72K
Hamad Ahmad MD PCCollierville, TN$363.91

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.